Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty

NCT04883034 | Unknown DMC

• 1 other identifier: ACB OUTPATIENT CLINIC
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased pain and analgesic consumption and may enhance the rehabilitation program

Conditions

Acute Pain; Total Knee Arthroplasty

Outcome Measures

Primary Outcomes (1)

• Visual analog pain score (VAS)

  A VAS scale was used to assess pain severity, with 0 indicating no pain and 10 indicating extreme pain

  one month

Secondary Outcomes (1)

• analgesic oral intake (etoricoxibe)

  one month

Study Arms (2)

pain management post total knee arthroplasty with analgetic oral

PLACEBO COMPARATOR

Patients in control group were given analgesic (etoricoxibe) on a daily basis, with the option to increase the dose if pain persisted, up to a maximum of 120 mg per day.

Drug: Analgesics, etoricoxibe

pain management post total knee arthroplasty with adductor canal block

ACTIVE COMPARATOR

On postoperative day 14 (POD 14), the ACB was performed for ACB group

Procedure: adductor canal block in outpatient clinic

Interventions

adductor canal block in outpatient clinic PROCEDURE

perform adductor canal block in outpatient clinic for patient post total knee arthroplasty

pain management post total knee arthroplasty with adductor canal block

Analgesics, etoricoxibe DRUG

anaelgetic oral intake

Also known as: etoricoxibe

pain management post total knee arthroplasty with analgetic oral

Eligibility Criteria

• Age: Up to 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Indonesian or Javanese-speaking adults
• After perfomed total knee replacement
• American Society of Anesthesiologists physical status I-III
• body mass index (BMI) of 18-40 kg/m2

You may not qualify if:

• Declined to complete the study
• Unable to cooperate
• had an allergic reaction to any of the drugs
• abusing alcohol or drugs

Sponsors & Collaborators

• Gadjah Mada University: lead

Study Sites (1)

Sholahuddin Rhatomy

Sleman, Special Region of Yogyakarta, 55281, Indonesia

RECRUITING

MeSH Terms

Conditions

Acute Pain

Interventions

Ambulatory Care Facilities; Analgesics

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Health Facilities; Health Care Facilities Workforce and Services; Sensory System Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Pharmacologic Actions; Chemical Actions and Uses; Central Nervous System Agents; Therapeutic Uses

Study Officials

• sholahuddin rhatomy, dr

  Gadjah Mada University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

sholahuddin rhatomy, Dr

CONTACT

+6281808720707; sholahuddin.rhatomy@ugm.ac.id

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head Of orthopaedic and Traumatology Department, Dr Soeradji Tirtonegoro Hospital/Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada

Study Record Dates

• First Submitted: April 30, 2021
• First Posted: May 12, 2021
• Study Start: June 1, 2020
• Primary Completion: June 1, 2021
• Study Completion: June 1, 2021
• Last Updated: May 12, 2021

Record last verified: 2021-05

Locations

ID (1)